Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 14288 publications
Treventis Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... and its locations and subsidiaries The report reviews current pipeline of Treventis Corporation’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Treventis Corporation’s pipeline products ...

Aug, 2014 22 pages
Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... Markets Direct’s, ‘Sol-Gel Technologies Ltd. - Product Pipeline Review - 2014’, provides an overview of the Sol-Gel Technologies Ltd.’s pharmaceutical research ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Sol-Gel Technologies Ltd.’s pipeline ...

Aug, 2014 18 pages
NeoPharm Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of NeoPharm Co., Ltd.’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NeoPharm Co., Ltd.’s pipeline products ...

Aug, 2014 31 pages
Molecular Templates Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Molecular Templates Inc.’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Molecular Templates Inc.’s pipeline products Reasons to ...

Aug, 2014 29 pages
Intezyne, Inc - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Intezyne, Inc’s pipeline products ... drug targets and therapeutic classes in the Intezyne, Inc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 27 pages
EyeCyte, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the EyeCyte, Inc.’s pipeline products ... drug targets and therapeutic classes in the EyeCyte, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 20 pages
Da Volterra - Product Pipeline Review - 2014 US$ 1,500.00

Summary Global Markets Direct’s, ‘Da Volterra - Product Pipeline Review - 2014’, provides an overview of the Da Volterra’s pharmaceutical research and development focus. This ... and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key ...

Aug, 2014 21 pages
CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2014 US$ 1,500.00

... (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the CYATHUS EXQUIRERE PharmaforschungsGmbH’s pipeline products Reasons ...

Aug, 2014 17 pages
AllTranz, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the AllTranz, Inc.’s pipeline products ... drug targets and therapeutic classes in the AllTranz, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 21 pages
US CNS Disorders Drug Pipeline Insight 2014 US$ 2,400.00

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an ... along with launch of novel drugs will drive the growth of CNS disease market in future. “US CNS Disorders Drug Pipeline Insight 2014” Report ...

Aug, 2014 1700 pages
Fatty Liver Disease Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Clinical Trials Review, H2, 2014' provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data ... conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors ...

Aug, 2014 85 pages
Critical Limb Ischemia Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Clinical Trials Review, H2, 2014' provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

Aug, 2014 78 pages
Coronary Stenosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Coronary Stenosis clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 78 pages
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Coronary Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe ...

Aug, 2014 83 pages
Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 60 pages
Global Multiple Sclerosis Drugs Market 2014-2018 US$ 3,000.00

... the present scenario and the growth prospects of the Global Multiple Sclerosis Drugs market for the period 2014-2018. To calculate the market ... Acorda Active Biotech GlaxoSmithKline Glenmark Mitsubishi Tanabe Opexa Pfizer Sanofi Market Driver Unmet Medical Needs For a full, detailed list, view our ...

Aug, 2014 102 pages
Global Meningococcal Vaccines Market 2014-2018 US$ 2,500.00

... to grow at a CAGR of 15.00 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the ... caused by different serogroups of Neisseria meningitides. TechNavio's report, the Global Meningococcal Vaccines Market 2014-2018, has been prepared based on an in-depth ...

Aug, 2014 78 pages
vasopharm GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the vasopharm GmbH’s pipeline products ... drug targets and therapeutic classes in the vasopharm GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 22 pages
Tacere Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Tacere Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Tacere Therapeutics, Inc.’s pipeline products Reasons to ...

Jul, 2014 27 pages
Phenomenome Discoveries, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Phenomenome Discoveries, Inc.’s pipeline products Reasons ... Assess the growth potential of Phenomenome Discoveries, Inc. in its therapy areas of focus Identify new drug targets and therapeutic classes in the ...

Jul, 2014 20 pages
Northern Antibiotics Oy - Product Pipeline Review - 2014 US$ 1,500.00

... its locations and subsidiaries The report reviews current pipeline of Northern Antibiotics Oy’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Northern Antibiotics Oy’s pipeline products ...

Aug, 2014 21 pages
Koronis Pharma, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Koronis Pharma, Inc.’s pipeline products Reasons to ... of focus Identify new drug targets and therapeutic classes in the Koronis Pharma, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce ...

Aug, 2014 24 pages
Haemostatix Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Haemostatix Ltd’s pipeline products ... drug targets and therapeutic classes in the Haemostatix Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 20 pages
Constellation Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Constellation Pharmaceuticals, Inc.’s pipeline products Reasons ...

Aug, 2014 20 pages
Cognosci, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Cognosci, Inc.’s pipeline products ... drug targets and therapeutic classes in the Cognosci, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 29 pages
CLL Pharma - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the CLL Pharma’s pipeline products ... new drug targets and therapeutic classes in the CLL Pharma’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 21 pages
ALSP, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ALSP, Inc.’s pipeline products ... new drug targets and therapeutic classes in the ALSP, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 19 pages
Adiga Life Sciences Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Adiga Life Sciences Inc. including business description, key information and facts, and its ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Adiga Life Sciences Inc.’s pipeline products ...

Aug, 2014 16 pages
US Orphan Drug Clinical Pipeline Insight 2014 US$ 2,000.00

... disorders, which are extremely life-threatening. As per the official definition, rare diseases are classified as those that affect fewer than 200, ... & FDA Regulatory Framework US Orphan Drug Pipeline by Phase, Indication & Company Marketed Orphan Drug Clinical Insight US Orphan Drug Clinical Pipeline: 570 ...

Aug, 2014 2000 pages
Global HIV Infection Drug Market & Pipeline Insight US$ 2,400.00

... cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years. The access ... are less promising. “Global HIV Infection Drug Market & Pipeline Insight” Report Highlight: Global HIV Infection Drug Market Overview & Incidence Scenario FDA ...

Aug, 2014 1350 pages
Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Clinical Trials Review, H2, 2014' provides data on the Vocal Cord Paralysis clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ...

Aug, 2014 50 pages
Vascular Dementias Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Vascular Dementias clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 69 pages
Upper Limb Muscle Spasticity Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Spasticity Global Clinical Trials Review, H2, 2014' provides data on the Upper Limb Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Upper Limb Muscle Spasticity. It includes an overview of the trial numbers and their recruitment ...

Aug, 2014 74 pages
Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Clinical Trials Review, H2, 2014' provides data on the Tropical Spastic Paraparesis clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Aug, 2014 51 pages
Trigeminal Neuralgia Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Trigeminal Neuralgia clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 60 pages
Trichotillomania Global Clinical Trials Review, H2, 2014 US$ 2,500.00

Summary GlobalData's clinical trial report, “Trichotillomania Global Clinical Trials Review, H2, 2014' provides data on the Trichotillomania clinical trial scenario. This ... by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs ...

Aug, 2014 51 pages
Tremor Global Clinical Trials Review, H2, 2014 US$ 2,500.00

Summary GlobalData's clinical trial report, “Tremor Global Clinical Trials Review, H2, 2014' provides data on the Tremor clinical trial scenario. This ... relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 61 pages
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Injury Global Clinical Trials Review, H2, 2014' provides data on the Traumatic Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Traumatic Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment ...

Aug, 2014 58 pages
Traumatic Pain Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Traumatic Pain clinical trial scenario. This report provides elemental information and data relating to the ... relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Aug, 2014 66 pages
Tourette Syndrome Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Trials Review, H2, 2014' provides data on the Tourette Syndrome clinical trial scenario. This report provides elemental information and data relating to the ... of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, ...

Jul, 2014 72 pages
Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Clinical Trials Review, H2, 2014' provides data on the Tick Borne Encephalitis clinical trial scenario. This report provides elemental information and data ... across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and ...

Jul, 2014 62 pages
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland US$ 1,995.00

Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland”. The report, an essential source of information and analysis, identifies key trends in the healthcare market and provides insights into the ...

Aug, 2014 252 pages
Cardiomyopathy Global Clinical Trials Review, H2, 2014 US$ 2,500.00

Summary GlobalData's clinical trial report, “Cardiomyopathy Global Clinical Trials Review, H2, 2014' provides data on the Cardiomyopathy clinical trial scenario. This ... for the key drugs for treating Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary ...

Aug, 2014 76 pages
Global Intranasal Drug Delivery Market 2014-2018 US$ 2,500.00

... and enhanced bioavailability. TechNavio's analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013- ... . The report includes a discussion of the key vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Becton, Dickinson ...

Aug, 2014 70 pages
Global Peptic Ulcer Drugs Market 2014-2018 US$ 2,500.00

... the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014–2018. To calculate the ... Pozen Rottapharm Madaus Taiho Pharmaceutical Zeria Pharmaceutical Zuventus Healthcare Market Driver Increased Incidence of H. pylori Infections. For a full, detailed list, ...

Aug, 2014 83 pages
Mauritius Pharmaceuticals and Healthcare Report Q4 2014 US$ 1,295.00

... , export growth will be slow due to the limited capacity of local drugmakers. Headline Expenditure Projections Pharmaceuticals: MUR6.00bn (USD195mn) in 2013 to MUR6.56bn (USD220mn) in 2014; 9.35% growth in local currency terms. Healthcare: MUR17.44bn (USD567mn) in 2013 to MUR18.36bn (USD617mn) in 2014; ...

Aug, 2014 52 pages
2014 Deep Research Report on Global and China Diabetes Drugs Industry US$ 2,200.00

2014 Deep Research Report on Global and China Diabetes Drugs Industry was professional and depth research report on Global and China ... application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis ...

Aug, 2014 166 pages
Umecrine Mood AB - Product Pipeline Review - 2014 US$ 1,500.00

... business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Umecrine Mood AB’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Umecrine Mood AB’s pipeline products ...

Jul, 2014 21 pages
Targazyme, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Targazyme, Inc.’s pipeline products ... drug targets and therapeutic classes in the Targazyme, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Jul, 2014 20 pages
Pherecydes Pharma SA - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Pherecydes Pharma SA’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pherecydes Pharma SA’s pipeline products ...

Jul, 2014 22 pages
1 2 3 4 5 >
Skip to top